M. Skasa et al., L-type calcium currents in atrial myocytes from patients with persistent and non-persistent atrial fibrillation, BAS R CARD, 96(2), 2001, pp. 151-159
Objective. In patients with persistent atrial fibrillation (AF), the atrial
myocardium is characterized by a reduced contractile force, by a shortened
duration of the action potential and a recently demonstrated reduction of
the L-type Ca2+ currents. We analyzed potential effects on L-type Ca2+ curr
ents of the patients' medication and of the duration of AF. Methods and res
ults. Human atrial myocytes were prepared from the right auricles of patien
ts undergoing open-heart surgery. Three groups of patients were studied: a
control group with sinus rhythm (SR, n = 26 patients) and a group with pers
istent AF (> 3 months duration; n = 10), a group with non-persistent AF (3
patients with SR but with documented episodes of AF in their history). L-ty
pe Ca2+ currents were measured during depolarizing pulses from a holding po
tential of-70 mV to a test potential of +10 mV and are given as mean +/- SE
M of current densities (currents normalized to the cell capacitance). Ca2current densities were significantly (p < 0.0001) smaller in cells from pat
ients with persistent AF than in control cells (0.54 <plus/minus> 0.08 pA/p
F vs. 1.96 +/- 0.12 pA/pF). No indication was found that these changes were
caused by medication with Ca2+ channel antagonists, beta blockers, or digi
talis. Stimulation with the dihydropyridine Bay K 8644 (1 muM) or with isop
roterenol (0.1 muM) increased Ca2+ currents in control cells 3.5 +/- 0.2 an
d 3.5 +/- 0.3-fold. In persistent AF, this increase was significantly large
r (6.0 +/- 0.5 and 5.2 +/- 0.6-fold) but stimulated currents were still sig
nificantly lower than in control cells. Patients with non-persistent AF exh
ibited Ca2+ currents well within the control range. Conclusion. A reduction
in Ca2+ currents, due to a reduction in number as well as a depression of
L-type channels, is a characteristic and pathophysiologically important par
t of the myocardial remodeling during long-lasting atrial fibrillation. It
is not present in patients with non-persistent AF and not caused by medicat
ion.